Bluebird Bio Share Price Today
(NASDAQ: BLUE)

Name: Bluebird Bio Share Price Today (NASDAQ: BLUE) - Bluebird Bio Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Bluebird Bio share price is $6.96 & ₹606.18 as on 5 Feb 2025, 2.30 'hrs' IST

$6.96

▲

-0.07

(-1%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Bluebird Bio share price in Dollar and Rupees. Guide to invest in Bluebird Bio stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bluebird Bio, along with analyst recommendations, forecasts, and comprehensive financials.

Bluebird Bio share price movements

Today's Low: $6.82
Today's High: $7.31
$6.96
2.01%
Downside
Day's Volatility :6.65%
Upside
4.73%
52 Weeks Low: $5.80
52 Weeks High: $38.40
$6.96
16.67%
Downside
52 Weeks Volatility :84.9%
Upside
81.88%

Bluebird Bio (BLUE) Returns

Period	Bluebird Bio, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-20.0%	0.5%	0.0%
6 Months	-62.72%	-2.3%	0.0%
1 Year	-62.61%	3.8%	0.0%
3 Years	-95.08%	11.4%	-11.7%

Bluebird Bio (BLUE) Key Statistics

in dollars & INR

Previous Close	$7.03
Open	$7.1
Today's High	$7.3059
Today's Low	$6.82
Market Capitalization	$75.3M
Today's Volume	$402.5K
52 Week High	$38.4
52 Week Low	$5.8
Revenue TTM	$54.9M
EBITDA	$-302.1M
Earnings Per Share (EPS)	$-36.0
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-186.7%

How to invest in Bluebird Bio Stock (BLUE) from India?

It is very easy for Indian residents to invest directly in Bluebird Bio from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bluebird Bio stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bluebird Bio or BLUE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bluebird Bio or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bluebird Bio shares which would translate to 0.125 fractional shares of Bluebird Bio as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bluebird Bio, in just a few clicks!

Returns in Bluebird Bio (BLUE) for Indian investors in Rupees

The Bluebird Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Bluebird Bio investment value today

Current value as on today

₹41,886

Returns

₹58,114

(-58.11%)

Returns from Bluebird Bio Stock

₹62,979 (-62.98%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Bluebird Bio (BLUE)

-77%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Bluebird Bio Stock from India on INDmoney has decreased by -77% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Bluebird Bio

BlackRock Inc
7.94%
Vanguard Group Inc
5.39%
Geode Capital Management, LLC
2.41%
State Street Corp
1.98%
FMR Inc
1.28%
Avidity Partners Management LP
0.84%

Analyst Recommendation on Bluebird Bio

Buy

50%Buy

40%Hold

10%Sell

Based on 20 Wall street analysts offering stock ratings for Bluebird Bio(by analysts ranked 0 to 5 stars)

Based on 20 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Bluebird Bio Stock (BLUE)

What analysts predicted

Upside of 273.56%

Target:

$26.00

Current:

$6.96

Insights on Bluebird Bio Stock (Ticker Symbol: BLUE)

Price Movement
In the last 7 days, BLUE stock has moved down by -9.4%
Decreasing Revenue
Revenue is down for the last 3 quarters, 18.57M → 10.61M (in $), with an average decrease of 23.7% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -81.39M → -60.80M (in $), with an average increase of 33.9% per quarter
BLUE vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.6% return, outperforming this stock by 121.8%
BLUE vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 88.8% return, outperforming this stock by 183.6%
Price to Sales
ForBLUE every $1 of sales, investors are willing to pay $19.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.6 for every $1 of sales.

BLUE Bluebird Bio Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$44.7M	↓ 18.15%
Net Income	$-789.6M	↑ 42.11%
Net Profit Margin	-1.8K%	↓ 749.47%

	FY20	Y/Y Change
Revenue	$250.7M	↑ 461.25%
Net Income	$-618.7M	↓ 21.65%
Net Profit Margin	-246.75%	↑ 1520.74%

	FY21	Y/Y Change
Revenue	$3.7M	↓ 98.54%
Net Income	$-562.6M	↓ 9.06%
Net Profit Margin	-15.4K%	↓ 15117.48%

	FY22	Y/Y Change
Revenue	$3.6M	↓ 1.77%
Net Income	$-266.6M	↓ 52.62%
Net Profit Margin	-7.4K%	↑ 7953.11%

	FY23	Y/Y Change
Revenue	$29.5M	↑ 720.04%
Net Income	$-211.9M	↓ 20.51%
Net Profit Margin	-718.42%	↑ 6692.7%

	FY24	Y/Y Change
Revenue	$29.5M	↑ 0.0%
Net Income	$-211.9M	↑ 0.0%
Net Profit Margin	-718.42%	↑ 0.0%

	Q2 FY23	Q/Q Change
Revenue	$6.9M	↑ 189.37%
Net Income	$-72.9M	↓ 314.16%
Net Profit Margin	-1.1K%	↓ 2487.95%

	Q3 FY23	Q/Q Change
Revenue	$12.4M	↑ 79.85%
Net Income	$-71.7M	↓ 1.61%
Net Profit Margin	-578.85%	↑ 479.32%

	Q4 FY23	Q/Q Change
Revenue	$7.8M	↓ 36.78%
Net Income	$-88.5M	↑ 23.4%
Net Profit Margin	-1.1K%	↓ 551.02%

	Q1 FY24	Q/Q Change
Revenue	$18.6M	↑ 137.08%
Net Income	$-69.8M	↓ 21.14%
Net Profit Margin	-375.84%	↑ 754.03%

	Q2 FY24	Q/Q Change
Revenue	$16.1M	↓ 13.31%
Net Income	$-81.4M	↑ 16.6%
Net Profit Margin	-505.52%	↓ 129.68%

	Q3 FY24	Q/Q Change
Revenue	$10.6M	↓ 34.09%
Net Income	$-60.8M	↓ 25.29%
Net Profit Margin	-573.01%	↓ 67.49%

	FY19	Y/Y Change
Profit	$41.7M	↓ 22.35%

	FY20	Y/Y Change
Profit	$245.3M	↑ 488.4%

	FY21	Y/Y Change
Profit	$-35.2M	↓ 114.35%

	FY22	Y/Y Change
Profit	$-6.5M	↓ 81.59%

	FY23	Y/Y Change
Profit	$-4.0M	↓ 37.81%

	FY24	Y/Y Change
Profit	$-4.0M	↑ 0.0%

	Q2 FY23	Q/Q Change
Profit	$-2.7M	↑ 168.74%

	Q3 FY23	Q/Q Change
Profit	$1.4M	↓ 153.74%

	Q4 FY23	Q/Q Change
Profit	$-1.8M	↓ 225.12%

	Q1 FY24	Q/Q Change
Profit	$-7.3M	↑ 305.51%

	Q2 FY24	Q/Q Change
Profit	$-12.8M	↑ 76.18%

	Q3 FY24	Q/Q Change
Profit	$-1.2M	↓ 90.9%

	FY19	Y/Y Change
Operating Cash Flow	$-564.4M	↑ 36.51%
Investing Cash Flow	$507.8M	↓ 174.74%
Financing Cash Flow	$21.2M	↓ 97.13%

	FY20	Y/Y Change
Operating Cash Flow	$-470.4M	↓ 16.66%
Investing Cash Flow	$-84.3M	↓ 116.61%
Financing Cash Flow	$546.7M	↑ 2480.43%

	FY21	Y/Y Change
Operating Cash Flow	$-635.6M	↑ 35.14%
Investing Cash Flow	$562.6M	↓ 766.97%
Financing Cash Flow	$-94.0M	↓ 117.19%

	FY22	Y/Y Change
Operating Cash Flow	$-353.0M	↓ 44.47%
Investing Cash Flow	$250.5M	↓ 55.48%
Financing Cash Flow	$54.3M	↓ 157.74%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-72.7M	↓ 16.06%
Investing Cash Flow	$6.9M	↓ 91.54%
Financing Cash Flow	$-445.0K	↓ 100.34%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-61.8M	↓ 14.96%
Investing Cash Flow	$62.1M	↑ 793.92%
Financing Cash Flow	$-42.0K	↓ 90.56%

Bluebird Bio Technicals Summary

Sell

Neutral

Buy

Bluebird Bio is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Bluebird Bio (BLUE) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bluebird Bio, Inc.	-29.13%	-62.72%	-62.61%	-95.08%	-99.6%
Biontech Se	-0.32%	51.19%	24.81%	-30.66%	288.02%
Regeneron Pharmaceuticals, Inc.	-6.9%	-37.55%	-28.89%	7.15%	74.63%
Vertex Pharmaceuticals Incorporated	16.87%	0.96%	13.03%	93.36%	95.94%
Alnylam Pharmaceuticals, Inc.	17.76%	5.53%	59.46%	84.7%	118.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bluebird Bio, Inc.	NA	NA	0.32	-21.0	-1.87	-0.36	NA	1.01
Biontech Se	160.8	NA	0.04	-3.32	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	16.64	16.64	1.08	44.92	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.49	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bluebird Bio, Inc.	Buy	$75.3M	-99.6%	NA	0.0%
Biontech Se	Buy	$29.7B	288.02%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$74.0B	74.63%	16.64	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$118.9B	95.94%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$35.0B	118.8%	NA	-15.86%

About Bluebird Bio

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States. The company's product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. Its clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts.

Organization	Bluebird Bio
Employees	375
CEO	Mr. Andrew Obenshain
Industry	Health Technology

Management People of Bluebird Bio

Name	Title
Mr. Andrew Obenshain	President, CEO & Director
Mr. Thomas J. Klima	Chief Commercial Officer & COO
Mr. Richard A. Colvin M.D., Ph.D.	Chief Medical Officer
Mr. Oliver James Sterling III	CFO & Principal Accounting Officer
Mr. Joseph D. Vittiglio Esq., J.D.	Chief Legal & Business Officer and Secretary
Jess Rowlands	Head of Corporate Communications
Ms. Andrea Walton	Chief People Officer
Mr. Kasra Kasraian	Senior Vice President of Technical Development & Operations
Mr. Scott Shoemaker	Senior Vice President of Quality
Ms. Sarah Alspach	Senior Vice President of External Affairs

Important FAQs about investing in BLUE Stock from India :

What is Bluebird Bio share price today?

Bluebird Bio share price today stands at $6.96, Open: $7.10 ; Previous Close: $7.03 ; High: $7.31 ; Low: $6.82 ; 52 Week High: $38.40 ; 52 Week Low: $5.80.

The stock opens at $7.10, after a previous close of $7.03. The stock reached a daily high of $7.31 and a low of $6.82, with a 52-week high of $38.40 and a 52-week low of $5.80.

Can Indians buy Bluebird Bio shares?

Yes, Indians can invest in the Bluebird Bio (BLUE) from India.

With INDmoney, you can buy Bluebird Bio at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Bluebird Bio at zero transaction cost.

How can I buy Bluebird Bio shares from India?

It is very easy to buy Bluebird Bio from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bluebird Bio (BLUE) be purchased?

Yes, you can buy fractional shares of Bluebird Bio with INDmoney app.

What are the documents required to start investing in Bluebird Bio stocks?

To start investing in Bluebird Bio, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.